Literature DB >> 10023498

Psychosexual effects of three doses of testosterone cycling in normal men.

W R Yates1, P J Perry, J MacIndoe, T Holman, V Ellingrod.   

Abstract

BACKGROUND: Testosterone is receiving increased attention for contraceptive and therapeutic indications. The potential psychosexual side effects of testosterone therapy and withdrawal are unclear.
METHODS: Healthy men between the ages of 21 and 40 years were recruited via advertisement for a randomized, controlled, double-blind study of acute and withdrawal effects of three doses of testosterone. Two weeks of placebo injections were followed by one of three randomized weekly doses of testosterone cypionate (100 mg, 250 mg, or 500 mg) for the next 14 weeks. Twelve weeks of placebo injections followed during the withdrawal phase of the study. Psychosexual effects were monitored throughout the study.
RESULTS: All doses of testosterone demonstrated only minimal effects on measures of mood and behavior during acute and withdrawal phases for all study completers. There were no effects on psychosexual function. There was no evidence of a dose-dependent effect on any measure. One noncompleter on 500 mg of testosterone developed a brief syndrome with symptoms similar to an agitated and irritable mania.
CONCLUSIONS: Doses of testosterone up to five times physiologic replacement dose appear to have minimal risk of adverse psychosexual effects in the majority of normal men; however, beginning at around 500 mg per week of testosterone cypionate, a minority of normal men may experience significant adverse psychological effects. Because illicit anabolic steroid users may use larger doses of multiple drugs under less restrictive conditions, our study may significantly underestimate the psychological effect of steroid use in the community.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10023498     DOI: 10.1016/s0006-3223(98)00028-6

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN: 0006-3223            Impact factor:   13.382


  21 in total

1.  Trends in non-medical use of anabolic steroids by U.S. college students: results from four national surveys.

Authors:  Sean Esteban McCabe; Kirk J Brower; Brady T West; Toben F Nelson; Henry Wechsler
Journal:  Drug Alcohol Depend       Date:  2007-05-23       Impact factor: 4.492

Review 2.  Neuropsychiatric effects of prescription drug abuse.

Authors:  Jason P Caplan; Lucy A Epstein; Davin K Quinn; Jonathan R Stevens; Theodore A Stern
Journal:  Neuropsychol Rev       Date:  2007-08-16       Impact factor: 7.444

Review 3.  Long-term psychiatric and medical consequences of anabolic-androgenic steroid abuse: a looming public health concern?

Authors:  Gen Kanayama; James I Hudson; Harrison G Pope
Journal:  Drug Alcohol Depend       Date:  2008-07-02       Impact factor: 4.492

4.  National Athletic Trainers' Association position statement: anabolic-androgenic steroids.

Authors:  Robert D Kersey; Diane L Elliot; Linn Goldberg; Gen Kanayama; James E Leone; Mike Pavlovich; Harrison G Pope
Journal:  J Athl Train       Date:  2012 Sep-Oct       Impact factor: 2.860

Review 5.  Adverse health consequences of performance-enhancing drugs: an Endocrine Society scientific statement.

Authors:  Harrison G Pope; Ruth I Wood; Alan Rogol; Fred Nyberg; Larry Bowers; Shalender Bhasin
Journal:  Endocr Rev       Date:  2013-12-17       Impact factor: 19.871

6.  Mood Symptoms in Steroid Users: The Unexamined Role of Concurrent Stimulant Use.

Authors:  Pilar M Sanjuan; James L Langenbucher; Tom Hildebrandt
Journal:  J Subst Use       Date:  2015-09-18

Review 7.  Illicit anabolic-androgenic steroid use.

Authors:  Gen Kanayama; James I Hudson; Harrison G Pope
Journal:  Horm Behav       Date:  2009-09-18       Impact factor: 3.587

Review 8.  Anabolic-androgenic steroid dependence? Insights from animals and humans.

Authors:  Ruth I Wood
Journal:  Front Neuroendocrinol       Date:  2008-01-03       Impact factor: 8.606

Review 9.  Androgen therapy in the aging male.

Authors:  Bruno Lunenfeld
Journal:  World J Urol       Date:  2003-10-24       Impact factor: 4.226

10.  Testosterone administration decreases generosity in the ultimatum game.

Authors:  Paul J Zak; Robert Kurzban; Sheila Ahmadi; Ronald S Swerdloff; Jang Park; Levan Efremidze; Karen Redwine; Karla Morgan; William Matzner
Journal:  PLoS One       Date:  2009-12-16       Impact factor: 3.752

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.